WBI-2100

N/A

Report date: 2025/01/26 16:28:06
NME

Base Information

Drug NameWBI-2100
Drug Alias NameWBI-2000 series (Welichem)WBI-2100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeutrophil modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWelichem Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesWelichem Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A